HUE063656T2 - Pegilált liposzómák és véralvadási faktorok gyógyszerészeti formulációi - Google Patents

Pegilált liposzómák és véralvadási faktorok gyógyszerészeti formulációi

Info

Publication number
HUE063656T2
HUE063656T2 HUE15775444A HUE15775444A HUE063656T2 HU E063656 T2 HUE063656 T2 HU E063656T2 HU E15775444 A HUE15775444 A HU E15775444A HU E15775444 A HUE15775444 A HU E15775444A HU E063656 T2 HUE063656 T2 HU E063656T2
Authority
HU
Hungary
Prior art keywords
pharmaceutical formulations
blood coagulation
coagulation factors
pegylated liposomes
pegylated
Prior art date
Application number
HUE15775444A
Other languages
English (en)
Hungarian (hu)
Inventor
William Henry
Original Assignee
Cantab Biopharmaceuticals Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Biopharmaceuticals Patents Ltd filed Critical Cantab Biopharmaceuticals Patents Ltd
Publication of HUE063656T2 publication Critical patent/HUE063656T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HUE15775444A 2014-10-06 2015-10-06 Pegilált liposzómák és véralvadási faktorok gyógyszerészeti formulációi HUE063656T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1417589.7A GB201417589D0 (en) 2014-10-06 2014-10-06 Pharmaceutical Formulations

Publications (1)

Publication Number Publication Date
HUE063656T2 true HUE063656T2 (hu) 2024-01-28

Family

ID=51946871

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15775444A HUE063656T2 (hu) 2014-10-06 2015-10-06 Pegilált liposzómák és véralvadási faktorok gyógyszerészeti formulációi

Country Status (16)

Country Link
US (2) US20170304203A1 (cg-RX-API-DMAC7.html)
EP (1) EP3204034B9 (cg-RX-API-DMAC7.html)
JP (3) JP2017531659A (cg-RX-API-DMAC7.html)
AU (1) AU2015330102B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017007031A2 (cg-RX-API-DMAC7.html)
CA (1) CA2994891C (cg-RX-API-DMAC7.html)
ES (1) ES2954134T3 (cg-RX-API-DMAC7.html)
GB (1) GB201417589D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20230985T1 (cg-RX-API-DMAC7.html)
HU (1) HUE063656T2 (cg-RX-API-DMAC7.html)
MX (1) MX384517B (cg-RX-API-DMAC7.html)
PL (1) PL3204034T3 (cg-RX-API-DMAC7.html)
RS (1) RS64461B1 (cg-RX-API-DMAC7.html)
RU (1) RU2737291C2 (cg-RX-API-DMAC7.html)
SM (1) SMT202300271T1 (cg-RX-API-DMAC7.html)
WO (1) WO2016055447A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201417589D0 (en) * 2014-10-06 2014-11-19 Cantab Biopharmaceuticals Patents Ltd Pharmaceutical Formulations
JP6825010B2 (ja) * 2016-05-26 2021-02-03 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 遠心法によるリポソーム調製のための方法及び装置

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US6326353B1 (en) 1993-03-23 2001-12-04 Sequus Pharmaceuticals, Inc. Enhanced circulation effector composition and method
ATE179599T1 (de) 1993-08-06 1999-05-15 Opperbas Holding Bv Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen
IL113010A0 (en) * 1994-03-31 1995-10-31 Pharmacia Ab Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US6156337A (en) * 1994-07-08 2000-12-05 Opperbas Holding B.V. Method for high loading of vesicles with biopolymeric substances
US6310183B1 (en) * 1997-09-10 2001-10-30 Novo Nordisk A/S Coagulation factor VIIa composition
ES2233036T3 (es) * 1998-04-27 2005-06-01 Opperbas Holding B.V. Composicion farmaceutica que comprende factor viii y liposomas neutros.
RU2250911C2 (ru) 1999-07-14 2005-04-27 Элзэ Копэрейшн Липосомальная композиция, нейтральный липополимер и способ увеличения времени циркуляции липосомы
JP5090605B2 (ja) * 2000-05-03 2012-12-05 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 凝固因子ｖｉｉの皮下投与
US20070141135A1 (en) 2005-06-29 2007-06-21 Balu-Lyer Sathy V Compositions and methods for less immunogenic protein-lipid complexes
US20030232075A1 (en) 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
ATE395101T1 (de) * 2003-04-15 2008-05-15 Opperbas Holding Bv Pharmazeutische zusammensetzung, enthaltend proteine und/oder polypeptide sowie kolloidpartikel
WO2008081024A1 (en) * 2007-01-03 2008-07-10 Novo Nordisk Health Care Ag Subcutaneous administration of coagulation factor viia-related popypeptdes
CA2701884A1 (en) 2007-10-15 2009-04-23 Wake Forest University Health Sciences Methods and compositions for printing biologically compatible nanotube composites of autologous tissue
EP2437726B1 (en) 2009-06-03 2018-05-16 Sequessome Technology Holdings Limited Formulations for the treatment of deep tissue pain
AU2010283998B2 (en) 2009-08-21 2015-01-29 Targeted Delivery Technologies Limited Vesicular formulations
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
GB201007357D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIII
TW201240664A (en) * 2010-09-01 2012-10-16 Portola Pharm Inc Methods and formulations of treating thrombosis with betrixaban and a P-glycoprotein inhibitor
GB2516388A (en) * 2012-04-16 2015-01-21 Cantab Biopharmaceuticals Patents Ltd Optimised subcutaneous therapeutic agents
GB201417589D0 (en) * 2014-10-06 2014-11-19 Cantab Biopharmaceuticals Patents Ltd Pharmaceutical Formulations

Also Published As

Publication number Publication date
PL3204034T3 (pl) 2023-11-06
AU2015330102A1 (en) 2017-05-25
RU2737291C2 (ru) 2020-11-26
BR112017007031A2 (pt) 2018-01-30
RS64461B1 (sr) 2023-09-29
JP7573582B2 (ja) 2024-10-25
US20190060235A1 (en) 2019-02-28
HRP20230985T1 (hr) 2023-12-08
JP2017531659A (ja) 2017-10-26
EP3204034C0 (en) 2023-06-07
MX384517B (es) 2025-03-14
CA2994891C (en) 2023-04-04
JP2020183446A (ja) 2020-11-12
CA2994891A1 (en) 2016-04-14
ES2954134T3 (es) 2023-11-20
AU2015330102B2 (en) 2021-01-28
SMT202300271T1 (it) 2023-09-06
US11484499B2 (en) 2022-11-01
EP3204034B9 (en) 2023-10-04
EP3204034A1 (en) 2017-08-16
RU2017115831A3 (cg-RX-API-DMAC7.html) 2019-05-06
MX2017004378A (es) 2018-02-09
RU2017115831A (ru) 2018-11-14
GB201417589D0 (en) 2014-11-19
EP3204034B1 (en) 2023-06-07
WO2016055447A1 (en) 2016-04-14
JP2023002687A (ja) 2023-01-10
US20170304203A1 (en) 2017-10-26

Similar Documents

Publication Publication Date Title
IL285179A (en) Pharmaceutical preparations containing synthetic glycans for use in the treatment of diseases of the digestive system and methods and methods for their preparation
IL279001A (en) Nasal medicines and methods of using them
IL265590B (en) Formulations and methods for keratin treatment
IL251834A0 (en) Pharmaceutical compositions containing peptide variants and methods of using them
ZA201703163B (en) Rna guided eradication of human jc virus and other polyomaviruses
ZA201807128B (en) Pegylated liposomes and methods of use
EP3202305A4 (en) Disposable endoscope and system
EP3131566A4 (en) Bi-terminal pegylated integrin-binding peptides and methods of use thereof
GB201500314D0 (en) Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
IL256515A (en) Therapeutic peptides and methods of use thereof
SG11201707816PA (en) Patient interface and aspects thereof
PT3380525T (pt) Formulações farmacêuticas e métodos que as utilizam
IL248210A0 (en) Methods and compositions for the treatment of vascular malformation
EP3313427A4 (en) Therapeutic peptides and methods of use thereof
ZA201802134B (en) Therapeutic compounds and methods of use thereof
GB201406172D0 (en) Therapy and pharmaceutical composition
HUE063656T2 (hu) Pegilált liposzómák és véralvadási faktorok gyógyszerészeti formulációi
KR20180085033A (ko) 피부 질환 치료용 약학적 제형 및 이의 제조 방법
HUE061056T2 (hu) Készítmény meddõség kezelésére nõi betegnél
GB201410869D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
IL257689A (en) Pharmacological preparations and methods for the treatment of diseases associated with hypoxia
GB201408449D0 (en) Motion-activated therapeutic disposable pillowcase
GB201414414D0 (en) Formulations of generic drugs against cancer and infectious diseases